ANIK — Anika Therapeutics Inc.
4 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about ANIK (2026-11-07)
- ANIK reported Q3 2026 earnings with gross margins expanding 560 bps YoY to 61.6%.
- The company's net loss narrowed to $0.3M from $2.3M in the prior year period.
- Nine-month operating expenses rose only 10.7% against 20.9% gross profit growth.
| GDELT | 3 | news |
| Bluesky | 1 | community |
| Marketaux | 0 | news |
| RSS Bundle | 0 | news |
| SEC EDGAR 8-K | 0 | filings |